S

Active Director Director DIN 11121087
DIN 11121087 First appointment Apr 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value •••• Premium profile

About Saurabh

Data last updated:

Saurabh is a Director at Kuemen Laboratories Private Limited (since 2025). The company operates in Pharma. Kuemen Laboratories Private Limited reported revenue of ₹10.60 Cr (FY 2025).

DIN 11121087
Primary Designation Director
Industry Pharma
First Appointment 18 Apr 2025
Oldest Company Age 35 yrs
Largest company Kuemen Laboratories Private Limited · ₹10.60 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kuemen Laboratories Private Limited U74899DL1991PTC044697
Director18 Apr 20251991₹10.60 Cr (FY 2025)Active

Board colleagues of Saurabh

Directorship timeline

Open interactive timeline →
Kuemen Laboratories Private Limited
Premium access

Shareholding and investment profile for Saurabh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Saurabh

Saurabh currently holds 1 directorship: Kuemen Laboratories Private Limited (Director, since 18 Apr 2025, revenue ₹10.60 Cr (FY 2025)).

Saurabh was first appointed on 18 Apr 2025 as Director at Kuemen Laboratories Private Limited.

The current boards of Saurabh's companies include Madhu Goyal (Kuemen Laboratories Private Limited), Pawan Kumar Goyal (Kuemen Laboratories Private Limited), Puneet Goyal (Kuemen Laboratories Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available